Skip to main content
Veterinary Medicines

Api-Bioxal 44.2 mg/ml bee-hive solution

Authorised
  • Oxalic acid

Product identification

Medicine name:
Api-Bioxal 44.2 mg/ml bee-hive solution
Api-Bioxal 44,2 mg/ml raztopina za uporabo v čebeljem panju
Active substance:
  • Oxalic acid
Target species:
  • Honey bee
Route of administration:
  • In-hive use

Product details

Active substance and strength:
  • Oxalic acid
    44.20
    milligram(s)
    /
    1.00
    millilitre(s)
Pharmaceutical form:
  • Bee-hive solution
Withdrawal period by route of administration:
  • In-hive use
    • Honey bee
      • Honey
        0
        day
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QP53AG03
Authorisation status:
  • Valid
Authorised in:
  • Slovenia
Available in:
  • Slovenia
Package description:

Additional information

Entitlement type:
  • Marketing Authorisation
Marketing authorisation holder:
  • Chemicals Laif S.p.A.
Marketing authorisation date:
Manufacturing sites for batch release:
  • Chemifarma S.p.A.
Responsible authority:
  • Agency For Medicinal Products And Medical Devices Of The Republic Of Slovenia
Authorisation number:
  • MR/V/0511/002
Date of authorisation status change:
Reference member state:
  • Italy
Procedure number:
  • IT/V/0132/002
Concerned member states:
  • Austria
  • Bulgaria
  • Croatia
  • Ireland
  • Norway
  • Portugal
  • Romania
  • Slovenia
  • Spain
  • United Kingdom (Northern Ireland)

Documents

Combined File of all Documents

English (PDF)
Published on: 11/11/2024
Download

Summary of Product Characteristics

This document does not exist in this language (English). You can find it in another language below.
Slovenian (PDF)
Published on: 21/03/2025

Package Leaflet and Labelling

This document does not exist in this language (English). You can find it in another language below.
Slovenian (PDF)
Published on: 21/03/2025
How useful was this page?:
No votes yet
"Please do not include any personal data, such as your name or contact details. If you do, you consent to the processing of that data in accordance with EMA’s Privacy Statement concerning requests for information or access to documents. If you would like a reply from EMA, please Send a question to EMA instead."